A Study of SGN-B7H4V in Advanced Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Ovarian Neoplasms|Peritoneal Neoplasms|Fallopian Tube Neoplasms|Triple Negative Breast Neoplasms|HER2 Negative Breast Neoplasms|Hormone Receptor Positive Breast Neoplasms|Endometrial Neoplasms|Carcinoma, Non-Small-Cell Lung|Cholangiocarcinoma|Gallbladder Carcinoma|Adenoid Cystic Carcinoma
Interventions: DRUG: SGN-B7H4V
Sponsor: Seagen Inc.